The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 03, 2006

Filed:

Dec. 19, 2003
Applicants:

John A. Wendt, South Lyon, MI (US);

Heather Stenmark, Chicago, IL (US);

Hongwei Wu, Buffalo Grove, IL (US);

Yaping Wang, Acton, MA (US);

Barbara B. Chen, Northbrook, IL (US);

Thomas D. Penning, Elmhurst, IL (US);

Victoria L. Downs, Pinckney, MI (US);

Mark L. Boys, Brighton, MI (US);

Mark Russell, Gurnee, IL (US);

Dale P. Spangler, San Diego, CA (US);

Inventors:

John A. Wendt, South Lyon, MI (US);

Heather Stenmark, Chicago, IL (US);

Hongwei Wu, Buffalo Grove, IL (US);

Yaping Wang, Acton, MA (US);

Barbara B. Chen, Northbrook, IL (US);

Thomas D. Penning, Elmhurst, IL (US);

Victoria L. Downs, Pinckney, MI (US);

Mark L. Boys, Brighton, MI (US);

Mark Russell, Gurnee, IL (US);

Dale P. Spangler, San Diego, CA (US);

Assignee:

Pharmacia Corporation, St. Louis, MO (US);

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/55 (2006.01); A61K 31/5025 (2006.01); A61K 31/44 (2006.01); A61K 31/425 (2006.01); A61K 31/36 (2006.01); C07D 401/00 (2006.01); C07D 417/00 (2006.01); C07D 413/00 (2006.01); C07D 471/02 (2006.01); C07D 207/00 (2006.01); C07D 317/46 (2006.01);
U.S. Cl.
CPC ...
Abstract

The present invention relates to a class of compounds represented by the Formula I or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising compounds of the Formula I, and methods of selectively inhibiting or antagonizing the αβand/or the αβintegrin without significantly inhibiting the αβintegrin.


Find Patent Forward Citations

Loading…